Advertisement

Retinal Neovascular Disorders: Mouse Models for Drug Development Studies

  • Rosanne M. Yetemian
  • Cheryl M. CraftEmail author
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 723)

Abstract

Neovascularization is a hallmark of several eye diseases leading to visual impairment, and its epidemiological impact is substantial (Lee et al. 1998). In retinal degenerative disease models, neovascularization is the process by which the choroid and/or retina become infiltrated with new blood vessels. In retinal neovascularization (RNV), sprouting retinal vessels penetrate the inner limiting membrane (ILM) and grow into the vitreous, and in some cases, grow through the avascular outer retina into the subretinal space (Campochiaro 2000). Numerous clinical and ­experimental observations indicate that ischemia (or hypoxia) is the driving force behind RNV (Michaelson and Steedman 1949). Occlusion of retinal vessels leading to ischemia is a feature of diseases with RNV, including diabetic retinopathy (DR) and retinopathy of prematurity (ROP) (Campochiaro 2000).

Keywords

Retinal neovascularization Neovascular disorders Age-related macular degeneration Diabetic retinopathy Retinopathy of prematurity Mouse models Drug development 

Notes

Acknowledgments

We thank members of the Mary D. Allen Laboratory for scientific discussions. CMC is the Mary D. Allen Chair in Vision Research, DEI, and a Research to Prevent Blindness (RPB) Senior Scientific Investigator. This work was supported, in part, by NIH Grant EY015851 (CMC), EY03040 (DEI), RPB (DEI & CMC), Dorie Miller, William Hansen Sandberg Memorial Scholarship (RMY), Tony Gray Foundation, Mary D. Allen Foundation (Dr. Richard Newton Lolley Memorial Scholarship [RMY]), and an RD2010 Travel Award (RMY).

References

  1. Ambati J, Anand A, Fernandez S et al. (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9:1390–1397PubMedCrossRefGoogle Scholar
  2. Ashton N (1966) Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The 33 Francis I. Proctor Lecture. Am J Ophthalmol 62:412–435PubMedGoogle Scholar
  3. Besirli CG, Johnson MW (2009) Proliferative diabetic retinopathy. Mayo Clin Proc 84:1054PubMedCrossRefGoogle Scholar
  4. Campochiaro PA (2000) Retinal and choroidal neovascularization. J Cell Physiol 184:301–310PubMedCrossRefGoogle Scholar
  5. Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10:133–140PubMedCrossRefGoogle Scholar
  6. Eyetech Study Group (2002) Preclinical and phase 1A clinical evaluation of an anti-VEGF ­pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retins 22:43–52PubMedCrossRefGoogle Scholar
  7. Das A, McGuire PG (2003) Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog Retin Eye Res 22:721–748PubMedCrossRefGoogle Scholar
  8. Grossniklaus HE, Kang SJ, Berglin L (2010) Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 29:500–519PubMedCrossRefGoogle Scholar
  9. Hahn P, Qian Y, Dentchev T et al. (2004) Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 101:13850–13855PubMedCrossRefGoogle Scholar
  10. Ham DI, Chang K, Chung H (1997) Preretinal neovascularization induced by experimental retinal vein occlusion in albino rats. Korean J Ophthalmol 11:60–64PubMedGoogle Scholar
  11. Heckenlively JR, Hawes NL, Friedlander M et al. (2003) Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 23:518–522PubMedCrossRefGoogle Scholar
  12. Katsuaki M, Akiko M, Matsuoka M et al. (2009) Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor. Ophthalmology 116:1748–1754CrossRefGoogle Scholar
  13. Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Survey of Ophthalmology 43:245–269PubMedCrossRefGoogle Scholar
  14. Lolley, RN, Schmidt, SY, Farber DB (1974) Alterations in cyclic AMP metabolism associated with photoreceptor degeneration in C3H mouse. J Neurochem 22:701–707PubMedCrossRefGoogle Scholar
  15. Malek G, Johnson LV, Mace BE et al. (2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci USA 102:11900–11905PubMedCrossRefGoogle Scholar
  16. Michaelson IC, Steedman HF (1949) Injection of the retinal vascular system in enucleated eyes. Br J Ophthalmol 33:376–379PubMedCrossRefGoogle Scholar
  17. Miller JW (1997) Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 151:13–23PubMedGoogle Scholar
  18. Ohno-Matsui K, Hirose A, Yamamoto S, et al. (2002) Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol. 160:711–719PubMedCrossRefGoogle Scholar
  19. Qazi Y, Maddula S, Ambati BK (2009) Mediators of ocular angiogenesis. J Genet 88:495–515PubMedCrossRefGoogle Scholar
  20. Rakoczy PE, Zhang D, Robertson T, et al. (2002) Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am J Pathol 161:1515–1524PubMedCrossRefGoogle Scholar
  21. Ryan SJ (1979) The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc 77:707–745PubMedGoogle Scholar
  22. Smith RS, Simon JW, Zabeleta A et al. (1999) The bst locus on mouse chromosome 16 is associated with age-related subertinal novasclarization. PNAS 97:2191–2195CrossRefGoogle Scholar
  23. Ting AY, Lee TK, MacDonald IM (2009) Genetics of age-related macular degeneration. Curr Opin Ophthalmol 20:369–376PubMedCrossRefGoogle Scholar
  24. Tobe T, Ortega S, Luna JD et al. (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641–1646PubMedCrossRefGoogle Scholar
  25. Wright AF, Chakarova CF, Abd El-Aziz MM et al. (2010) Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet 11:273–284PubMedCrossRefGoogle Scholar
  26. Yetemian RY, Brown BM, Craft CM (2010) Neovascularization, enhanced inflammatory response, and age-related cone dystrophy in the Nrl −/− Grk1 −/− mouse retina. Invest Ophthalmol Vis Sci 51:6196–6206Google Scholar
  27. Yetemian RY (2010) Elements of photoreceptor homeostasis: investigating phenotypic manifestations and susceptibility to photoreceptor degeneration in genetic knockout models for retinal disease. Dissertation. University of Southern California. ProQuest, LLC. Ann Arbor, MIGoogle Scholar
  28. Zhu X, Brown BM, Li A, et al. (2003) GRK1-dependent phosphorylation of S and M opsins and their binding to cone arrestin during cone phototransduction in the mouse retina. Journal of Neurosci 23:6152–6160Google Scholar
  29. Zhu X, Brown BM, Rife L, Craft CM (2006) Slowed photoresponse recovery and age related degeneration in cones lacking G protein-coupled receptor kinase 1. In Advances in Experimental Medicine and Biology, Retinal Degenerative Diseases 572:133–139. Hollyfield JG, Anderson RE, LaVail MM, eds. SpringerGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Mary D. Allen Laboratory for Vision Research, Doheny Eye Institute, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA
  2. 2.Department of OphthalmologyKeck School of Medicine of the University of Southern CaliforniaLos AngelesUSA
  3. 3.Regulatory AffairsAbbott Medical Optics, Inc.Santa AnaUSA
  4. 4.Department of Cell & NeurobiologyKeck School of Medicine of the University of Southern CaliforniaLos AngelesUSA

Personalised recommendations